In today’s recent session, 0.88 million shares of the Immutep Limited ADR (NASDAQ:IMMP) have been traded, and its beta is 1.78. Most recently the company’s share price was $2.06, and it changed around -$0.43 or -17.20% from the last close, which brings the market valuation of the company to $301.09M. IMMP at last check was trading at a discount to its 52-week high of $3.34, offering almost -62.14% off that amount. The share price’s 52-week low was $1.32, which indicates that the recent value has risen by an impressive 35.92% since then.
Immutep Limited ADR stock received a consensus recommendation rating of Buy, based on a mean score of 1.50. If we narrow it down even further, the data shows that 0 out of 2 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended IMMP as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight.
Immutep Limited ADR (NASDAQ:IMMP) trade information
Instantly IMMP has been showing red trend so far today with a performance of -17.20% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 2.71 on recent trading dayincreased the stock’s daily price by 23.99%. The company’s shares are currently down -4.99% year-to-date, but still up 19.17% over the last five days. On the other hand, Immutep Limited ADR (NASDAQ:IMMP) is 37.45% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $3.5, which translates to bulls needing to increase their stock price by 41.14% from its current value. Analyst projections state that IMMP is forecast to be at a low of $3.5 and a high of $3.5.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 9.98%. Immutep Limited ADR earnings are expected to increase by -5.29% in 2025, but the outlook is negative -0.39% per year for the next five years.
IMMP Dividends
Immutep Limited ADR’s next quarterly earnings report is expected to be released in June.
MERIDIAN WEALTH MANAGEMENT, LLC, with 0.0314% or 0.38 million shares worth $0.77 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
iShares Trust-iShares Biotechnology ETF and Brighthouse Fd.s TRT II-Brighthouse/Dimensional Intl Small Company POR were the top two Mutual Funds as of Mar 31, 2025 . The former held 648.31 shares worth $1.32 million, making up 0.44% of all outstanding shares. On the other hand, Brighthouse Fd.s TRT II-Brighthouse/Dimensional Intl Small Company POR held roughly 8.89 shares worth around $18127.0, which represents about 0.01% of the total shares outstanding.
